Partner 3: Università degli Studi di Milano (UMIL)
The Università degli Studi di Milano will participate through the Istituto di Pediatria.
The Istituto di Pediatria at the Università degli Studi di Milano represents a leader centre in Italy for research and clinical activities in paediatric infectious diseases. The institution has a huge experience in clinical trials as well as in multicentric collaborations, as could be evaluated by the large amount of its members’ international publications.
It has a Neonatology Unit with 7,000 births per year and with 1,200 babies hospitalized in the Neonatal Intensive Care Unit, 35,000 infants and children who attended the Emergency Room, 300 paediatric patients hospitalized in paediatric intensive care unit, 3,000 paediatric patients hospitalized in the pediatric wards, 3,000 pediatric patients followed in day hospital and 12,000 pediatric patients who attended the outpatient clinic. A total of 18 neonatologists, 30 pediatricians, 80 pediatric nurses and 30 pediatric residents regularly work in the different sections of the Institute.
The main institution’s activities have concerned methods of rationalising antibiotic therapy, therapeutic approach to invasive infections, diagnostic and therapeutic procedures in respiratory infections, neonatal infections as well as vaccines and preventive pediatrics.
The Istituto di Pediatria at the Università degli Studi di Milano has coordinated several epidemiological studies on the role of different pathogens in the principle pediatric infections as well as controlled clinical trials of optimal therapeutic regimens for some pediatric infectious diseases and has written Italian guidelines for diagnostic and therapeutic approach to some pediatric infectious diseases. Its role and its activities are recognized by the Italian Society of Pediatrics and the Italian Society for Pediatric Infectious Diseases.
On the basis of this experience in pediatric infectious diseases and in antibiotic therapy as well as on the basis of the high number of neonatal patients who regularly are followed in the institution, we could represent a real workpackage leader group for a study such as the one with meropenem that evaluates the use of an off-label antibiotic in neonatal sepsis and meningitis.
UMIL will coordinate the participation in Neomero of 4 NICUs in the Milan and Turin area (Clinica Mangiagalli, Niguarda Hospital, Sangereardo Hospital and Sant Anna Hospital in Turin), estimating to see about 250 Late onset Sepsis per year and about 7 cases of neonatal meningitis.
The Istituto di Pediatria at the Università degli Studi di Milano represents a leader centre in Italy for research and clinical activities in paediatric infectious diseases. The institution has a huge experience in clinical trials as well as in multicentric collaborations, as could be evaluated by the large amount of its members’ international publications.
It has a Neonatology Unit with 7,000 births per year and with 1,200 babies hospitalized in the Neonatal Intensive Care Unit, 35,000 infants and children who attended the Emergency Room, 300 paediatric patients hospitalized in paediatric intensive care unit, 3,000 paediatric patients hospitalized in the pediatric wards, 3,000 pediatric patients followed in day hospital and 12,000 pediatric patients who attended the outpatient clinic. A total of 18 neonatologists, 30 pediatricians, 80 pediatric nurses and 30 pediatric residents regularly work in the different sections of the Institute.
The main institution’s activities have concerned methods of rationalising antibiotic therapy, therapeutic approach to invasive infections, diagnostic and therapeutic procedures in respiratory infections, neonatal infections as well as vaccines and preventive pediatrics.
The Istituto di Pediatria at the Università degli Studi di Milano has coordinated several epidemiological studies on the role of different pathogens in the principle pediatric infections as well as controlled clinical trials of optimal therapeutic regimens for some pediatric infectious diseases and has written Italian guidelines for diagnostic and therapeutic approach to some pediatric infectious diseases. Its role and its activities are recognized by the Italian Society of Pediatrics and the Italian Society for Pediatric Infectious Diseases.
On the basis of this experience in pediatric infectious diseases and in antibiotic therapy as well as on the basis of the high number of neonatal patients who regularly are followed in the institution, we could represent a real workpackage leader group for a study such as the one with meropenem that evaluates the use of an off-label antibiotic in neonatal sepsis and meningitis.
UMIL will coordinate the participation in Neomero of 4 NICUs in the Milan and Turin area (Clinica Mangiagalli, Niguarda Hospital, Sangereardo Hospital and Sant Anna Hospital in Turin), estimating to see about 250 Late onset Sepsis per year and about 7 cases of neonatal meningitis.